[1]
“A supplementary report on the toxic manifestations of CHOP regimen in subjects with intermediate grade NHL”, Int Curr Pharm J, vol. 1, no. 10, pp. 322–327, Sep. 2012, doi: 10.3329/icpj.v1i10.11850.